The relationship between pro-resorptive inflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 693-697

  Karim, Yousuf ^a   Turner, Charles ^b   Dalton, Neil ^b   Roplekar, Rakshita ^a   Sankaralingam, Arun ^a   Ewang, Mfon ^a   Fogelman, Ignac ^c   Hampson, Geeta ^a,c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Bone resorption; Chemokines; Cytokines; Vitamin D

Indexed keywords

CYTOKINE; DICKKOPF 1 PROTEIN; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADULT; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CORRELATIONAL STUDY; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BONE RESORPTION; CHEMOKINES; CYTOKINES; VITAMIN D;

AGED; CYTOKINES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84884257545     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.08.010     Document Type: Article

References (40)

1. H. Takayanagi Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat Rev Immunol 7 4 2007 292 304
2. D. Jones, L.H. Glimcher, and A.O. Aliprantis Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection J Clin Invest 121 7 2011 2534 2542
3. S.H. Lee, T.S. Kim, Y. Choi, and J. Lorenzo Osteoimmunology: cytokines and the skeletal system BMB Rep 41 7 2008 495 510
4. S. Wei, H. Kitaura, P. Zhou, F.P. Ross, and S.L. Teitelbaum IL-1 mediates TNF-induced osteoclastogenesis J Clin Invest 115 2 2005 282 290
5. C.W. Lowik, G. van der Pluijm, H. Bloys, K. Hoekman, O.L. Bijvoet, and L.A. Aarden Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis Biochem Biophys Res Commun 162 3 1989 1546 1552
6. M.I. Koenders, E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M.M. Helsen, and F.E. Di Padova Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1 Am J Pathol 167 1 2005 141 149
7. M.S. Bendre, D.C. Montague, T. Peery, N.S. Akel, D. Gaddy, and L.J. Suva Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease Bone 33 1 2003 28 37
8. T. Masuda, X. Deng, and R. Tamai Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation Int Immunopharmacol 9 9 2009 1115 1121
9. D.M. Shinar, M. Sato, and G.A. Rodan The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures Endocrinology 126 3 1990 1728 1735
10. C. Niehrs Function and biological roles of the Dickkopf family of Wnt modulators Oncogene 25 57 2006 7469 7481
11. T.N. Masckauchan, C.J. Shawber, Y. Funahashi, C.M. Li, and J. Kitajewski Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells Angiogenesis 8 1 2005 43 51
12. T. Ueland, K. Otterdal, T. Lekva, B. Halvorsen, A. Gabrielsen, and W.J. Sandberg Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis Arterioscler Thromb Vasc Biol 29 8 2009 1228 1234
13. D. Diarra, M. Stolina, K. Polzer, J. Zwerina, M.S. Ominsky, and D. Dwyer Dickkopf-1 is a master regulator of joint remodeling Nat Med 13 2 2007 156 163
14. A. Grey, M.A. Mitnick, U. Masiukiewicz, B.H. Sun, S. Rudikoff, and R.L. Jilka A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo Endocrinology 140 10 1999 4683 4690
15. S. Cenci, M.N. Weitzmann, C. Roggia, N. Namba, D. Novack, and J. Woodring Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha J Clin Invest 106 10 2000 1229 1237
16. P. D'Amelio, A. Grimaldi, S. Di Bella, S.Z. Brianza, M.A. Cristofaro, and C. Tamone Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis Bone 43 1 2008 92 100
17. H.F. DeLuca Overview of general physiologic features and functions of vitamin D Am J Clin Nutr 80 Suppl. 6 2004 1689S 1696S
18. H.A. Bischoff-Ferrari, W.C. Willett, J.B. Wong, E. Giovannucci, T. Dietrich, and B. Dawson-Hughes Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials JAMA 293 18 2005 2257 2264
19. S. Boonen, P. Lips, R. Bouillon, H.A. Bischoff-Ferrari, D. Vanderschueren, and P. Haentjens Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials J Clin Endocrinol Metab 92 4 2007 1415 1423
20. H.A. Bischoff-Ferrari, W.C. Willett, J.B. Wong, A.E. Stuck, H.B. Staehelin, and E.J. Orav Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials Arch Intern Med 169 6 2009 551 561
21. K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, and D. Young Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial JAMA 303 18 2010 1815 1822
22. H. Smith, F. Anderson, H. Raphael, P. Maslin, S. Crozier, and C. Cooper Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial Rheumatology (Oxford) 46 12 2007 1852 1857
23. P.A. Baldock, G.P. Thomas, J.M. Hodge, S.U. Baker, U. Dressel, and P.D. O'Loughlin Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast J Bone Miner Res 21 10 2006 1618 1626
24. K. Ikeda Vitamin D, osteoclastogenesis and bone resorption: from mechanistic insight to the development of new analogs Endocr J 54 1 2007 1 6
25. M. Hewison Vitamin D, and immune function: an overview Proc Nutr Soc 71 1 2012 50 61
26. C. Turner, N. Dalton, R. Inaoui, I. Fogelman, W.D. Fraser, and G. Hampson Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency J Clin Endocrinol Metab 98 2 2013 550 556
27. R. Baron, and E. Hesse Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives J Clin Endocrinol Metab 97 2 2012 311 325
28. J. He, Z. Liu, Y. Zheng, J. Qian, H. Li, and Y. Lu p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction Cancer Res 72 24 2012 6393 6402
29. V.J. Woeckel, M. Koedam, J. van de Peppel, H. Chiba, B.C. van der Eerden, and J.P. van Leeuwen Evidence of vitamin D and interferon-beta cross-talk in human osteoblasts with 1alpha,25-dihydroxyvitamin D3 being dominant over interferon-beta in stimulating mineralization J Cell Physiol 227 9 2012 3258 3266
30. M. Yamaguchi, and M.N. Weitzmann High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro Int J Mol Med 29 5 2012 934 938
31. R. Kitazawa, K. Mori, A. Yamaguchi, T. Kondo, and S. Kitazawa Modulation of mouse RANKL gene expression by Runx2 and vitamin D3 J Cell Biochem 105 5 2008 1289 1297
32. M. Rossini, D. Gatti, O. Viapiana, E. Fracassi, L. Idolazzi, and S. Zanoni Short-term effects on bone turnover markers of a single high dose of oral vitamin D(3) J Clin Endocrinol Metab 97 4 2012 E622 E626
33. M. Rossini, S. Adami, O. Viapiana, E. Fracassi, L. Idolazzi, and M.R. Povino Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers Calcif Tissue Int 91 6 2012 365 369
34. R.L. Jilka, R.S. Weinstein, T. Bellido, A.M. Parfitt, and S.C. Manolagas Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines J Bone Miner Res 13 5 1998 793 802
35. S.K. Lee, A.E. Gardner, J.F. Kalinowski, S.L. Jastrzebski, and J.A. Lorenzo RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production Bone 38 5 2006 678 685
36. Y. Yamamoto, T. Yoshizawa, T. Fukuda, Y. Shirode-Fukuda, T. Yu, and K. Sekine Vitamin d receptor in osteoblasts is a negative regulator of bone mass control Endocrinology 154 3 2013 1008 1020
37. M.C. Izquierdo, M.V. Perez-Gomez, M.D. Sanchez-Nino, A.B. Sanz, O. Ruiz-Andres, and J. Poveda Klotho, phosphate and inflammation/ageing in chronic kidney disease Nephrol Dial Transplant 27 Suppl. 4 2012 iv6 iv10
38. T. Suyama, S. Okada, T. Ishijima, K. Iida, K. Abe, and Y. Nakai High phosphorus diet-induced changes in NaPi-IIb phosphate transporter expression in the rat kidney: DNA microarray analysis PLoS One 7 1 2012 e29483
39. J.F. Navarro-Gonzalez, C. Mora-Fernandez, M. Muros de Fuentes, J. Donate-Correa, V. Cazana-Perez, and J. Garcia-Perez Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients Clin J Am Soc Nephrol 6 9 2011 2272 2279
40. H. Tokuda, Y. Kanno, A. Ishisaki, M. Takenaka, A. Harada, and O. Kozawa Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts J Cell Biochem 91 5 2004 1053 1061